Charles River Laboratories International, Inc announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification. Accugenix NGS simultaneously sequences millions of individual DNA fragments from a sample and provides key information to pharmaceutical and personal care manufacturers regarding microbial control. When studying pure isolates and/or sequencing of mixed species environments, Accugenix […]

The post Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID first appeared on World Pharma Today.